DigestRedComo funciona
Red
/
Empresas
Ow
No verificado

Owkin

Sobre qué escribimos

BiotecnologíaIndustriaSaludSoftwareTécnica

15 Comunicados de prensa

Ver todos los comunicados de prensa
12/01/2026
Multimedia
Industria
Tecnología de la información
Salud
Técnica
Ciencia
Biotecnología
Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs
Fuente
Owkin
Editor
Business Wire
1.00
0
12/01/2026
Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences
Fuente
Owkin
Editor
Business Wire
1.00
0
12/01/2026
Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA
Fuente
Owkin
Editor
Business Wire
1.00
0
03/12/2025
Software
Ciencia
Farmacéutica
Tecnología de la información
Oncología
Técnica
Material médico sanitario
Medicina - Varios
Biotecnología
Salud
Industria
Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides
Fuente
Owkin
Editor
Business Wire
1.00
0
20/11/2025
Multimedia
Software
Ciencia
Tecnología de la información
Técnica
Universidad
Escuela/Educación
Biotecnología
Salud
Mercado laboral
Université Paris-Saclay and Owkin: A Unique Alliance to Propel University Medical Research to the Top of the European Rankings Through AI
Fuente
Owkin
Editor
Business Wire
1.00
0
18/11/2025
Owkin Unveils Europe’s First Pan-European Agentic Infrastructure for Biology at the Franco-German Digital Sovereignty Summit
Fuente
Owkin
Editor
Business Wire
1.00
0
13/11/2025
Técnica
Software
Biotecnología
Salud
Farmacéutica
Tecnología de la información
Industria
Owkin Announces Availability of K Pro in the AWS Marketplace SaaS Category
Fuente
Owkin
Editor
Business Wire
1.00
0
06/05/2025
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x
Fuente
Owkin
Editor
Business Wire
1.00
0
27/02/2025
Sanidad
Software
Farmacéutica
Oncología
Tecnología de la información
Técnica
Biotecnología
Salud
Industria
Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas
Fuente
Owkin
Editor
Business Wire
1.00
0
30/01/2025
Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors
Fuente
Owkin
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0